Stocks › ACHV
Achieve Life ACHV
US equityMarket cap rank #3472
$6.72 +$0.35 (+5.41%)
Market closed · Nov 6, 8:10 pm ET · Last extended-hours $6.65 -1.04%
Open$6.55
Prev close$6.38
Day range$6.25 – $6.75
Volume1.08M
Market cap$692.85M
P/E (TTM)–
Dividend yield–
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Institutional ownership84.5%-0.19 pts vs. prior quarter
Institutions holding136+7 vs. prior quarter
Insider trades (recent)36 buys / 9 sellsNet buying
Short interest17.27% of floatDays to cover 13.9 · as of 15 Oct 2026
Short-sale volume share27.5%5-day average of daily volume
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$4.74M (7 inflow days, 13 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 30.2% of shares outstanding.
Largest holders
By investor type
Reported short interest has risen from 15.85% to 17.27% of float over the last 6 biweekly reports (31 Jul 2026 to 15 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| Frazier Life Sciences Management, LP | VC/PE Fund | 2026/Q3 | +7,614,836 | 7.4% |
| TPG Capital, L.P. | VC/PE Fund | 2026/Q3 | +6,877,580 | 6.7% |
| venBio LLC | VC/PE Fund | 2026/Q3 | +5,914,720 | 5.7% |
| Logos Global Management, L.P. | Hedge Fund | 2026/Q3 | +5,425,000 | 5.3% |
| Paradigm Biocapital Advisors LP | Hedge Fund | 2026/Q3 | +4,951,856 | 4.8% |
| BlackRock | Mutual Fund | 2026/Q3 | +4,832,657 | 5.1% |
| Marshall Wace LLP | Hedge Fund | 2026/Q3 | +2,751,032 | 3.7% |
| VR Management, LLC | VC/PE Fund | 2026/Q3 | +2,751,032 | 2.7% |
| Janus Henderson Group plc | Mutual Fund | 2026/Q3 | +2,751,032 | 2.7% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +2,691,069 | 2.9% |
| Eventide Asset Management, LLC | Mutual Fund | 2026/Q3 | +2,220,000 | 2.2% |
| Vanguard Capital Management, LLC | Mutual Fund | 2026/Q3 | +2,213,672 | 4.6% |
| Alyeska Investment Group, L.P. | Hedge Fund | 2026/Q3 | +1,925,722 | 1.9% |
| Geode Capital Management, LLC | Mutual Fund | 2026/Q3 | +1,439,936 | 2.0% |
| Propel Bio Management, LLC | Mutual Fund | 2026/Q3 | +1,432,105 | 3.9% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 4 Oct 2026 | Benjamin Halladay | Chief Financial Officer | Other Derivative Acquisition | +200,000 | $7.01 | 200,000 |
| 18 Aug 2026 | Richard A. Stewart | Director | Open Market Disposition | -20,626 | $8.49 | 208,608 |
| 26 Jul 2026 | Richard A. Stewart | Director | Other Derivative Acquisition | +16,700 | – | 16,700 |
| 26 Jul 2026 | Richard A. Stewart | Director | Other Derivative Acquisition | +25,000 | $6.18 | 25,000 |
| 26 Jul 2026 | Jeffrey S. Farrow | Independent Director | Other Derivative Acquisition | +16,700 | – | 16,700 |
| 26 Jul 2026 | Jeffrey S. Farrow | Independent Director | Other Derivative Acquisition | +25,000 | $6.18 | 25,000 |
| 26 Jul 2026 | Aaron Royston | Independent Director | Other Derivative Acquisition | +16,700 | – | 16,700 |
| 26 Jul 2026 | Aaron Royston | Independent Director | Other Derivative Acquisition | +25,000 | $6.18 | 25,000 |
| 26 Jul 2026 | Thomas Sellig | Independent Director | Other Derivative Acquisition | +16,700 | – | 16,700 |
| 26 Jul 2026 | Thomas Sellig | Independent Director | Other Derivative Acquisition | +25,000 | $6.18 | 25,000 |
| 26 Jul 2026 | Nancy Phelan | Independent Director | Other Derivative Acquisition | +16,700 | – | 16,700 |
| 26 Jul 2026 | Nancy Phelan | Independent Director | Other Derivative Acquisition | +25,000 | $6.18 | 25,000 |
| 26 Jul 2026 | Reid Waldman | Independent Director | Other Derivative Acquisition | +16,700 | – | 16,700 |
| 26 Jul 2026 | Reid Waldman | Independent Director | Other Derivative Acquisition | +25,000 | $6.18 | 25,000 |
| 26 Jul 2026 | Christopher Martin | Independent Director | Other Derivative Acquisition | +16,700 | – | 16,700 |
| 26 Jul 2026 | Christopher Martin | Independent Director | Other Derivative Acquisition | +25,000 | $6.18 | 25,000 |
| 28 May 2026 | Jeffrey S. Farrow | Independent Director | Other Derivative Acquisition | +47,250 | $5.24 | 47,250 |
| 28 May 2026 | Reid Waldman | Independent Director | Other Derivative Acquisition | +47,250 | $5.24 | 47,250 |
| 10 May 2026 | Christopher Martin | Independent Director | Other Derivative Acquisition | +47,250 | $5.59 | 47,250 |
| 17 Apr 2026 | Andrew Goldberg | Chief Executive Officer | Other Derivative Acquisition | +1,800,965 | – | 1,800,965 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 15 Oct 2026 | 17,805,384 | 17.3% | 13.9 |
| 30 Sep 2026 | 17,474,108 | 17.0% | 10.9 |
| 15 Sep 2026 | 15,993,814 | 15.5% | 9.1 |
| 31 Aug 2026 | 16,447,645 | 16.0% | 12.2 |
| 14 Aug 2026 | 16,415,450 | 16.0% | 12.8 |
| 31 Jul 2026 | 16,273,408 | 15.9% | 15.0 |
No comments yet — be the first to weigh in on ACHV.
Sign in to join the discussion.